Simplex Trading’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $39.9K | Buy |
136
+13
| +11% | +$3.69K | ﹤0.01% | 6511 |
|
|
2026
Q1 | $34.3K | Buy |
+123
| New | +$35.4K | ﹤0.01% | 6250 |
|
|
2025
Q3 | – | Sell |
-35
| Closed | -$9.52K | – | 9064 |
|
|
2025
Q2 | $8K | Buy |
35
+23
| +192% | +$5.44K | ﹤0.01% | 7442 |
|
|
2025
Q1 | $2K | Sell |
12
-102
| -89% | -$30.7K | ﹤0.01% | 7929 |
|
|
2024
Q4 | $37K | Buy |
114
+79
| +226% | +$26.8K | ﹤0.01% | 6168 |
|
|
2024
Q3 | $11K | Sell |
35
-3,154
| -99% | -$1M | ﹤0.01% | 7108 |
|
|
2024
Q2 | $870K | Buy |
+3,189
| New | +$928K | ﹤0.01% | 3065 |
|
|
2023
Q4 | – | Sell |
-150
| Closed | -$47K | – | 8778 |
|
|
2023
Q3 | $53K | Sell |
150
-290
| -66% | -$112K | ﹤0.01% | 5749 |
|
|
2023
Q2 | $166K | Sell |
440
-531
| -55% | -$216K | ﹤0.01% | 4514 |
|
|
2023
Q1 | $465K | Buy |
971
+230
| +31% | +$108K | ﹤0.01% | 3347 |
|
|
2022
Q4 | $311K | Sell |
741
-1,401
| -65% | -$565K | ﹤0.01% | 3691 |
|
|
2022
Q3 | $893K | Buy |
+2,142
| New | +$1.07M | ﹤0.01% | 2783 |
|
|
2022
Q2 | – | Sell |
-287
| Closed | -$149K | – | 9962 |
|
|
2022
Q1 | $161K | Buy |
+287
| New | +$173K | ﹤0.01% | 5461 |
|
|
2021
Q4 | – | Sell |
-154
| Closed | -$115K | – | 10480 |
|
|
2021
Q3 | $101K | Hold |
154
| – | – | ﹤0.01% | 6605 |
|
|
2021
Q2 | $99K | Buy |
+154
| New | +$93.7K | ﹤0.01% | 6735 |
|
|
2021
Q1 | – | Sell |
-136
| Closed | -$80.5K | – | 8824 |
|
|
2020
Q4 | $79K | Buy |
+136
| New | +$77.5K | ﹤0.01% | 5675 |
|
|
2020
Q1 | – | Sell |
-838
| Closed | -$308K | – | 7590 |
|
|
2019
Q4 | $310K | Buy |
+838
| New | +$295K | ﹤0.01% | 3249 |
|
|
2017
Q2 | – | Sell |
-402
| Closed | -$80K | – | 6088 |
|
|
2017
Q1 | $80K | Buy |
+402
| New | +$77.4K | ﹤0.01% | 1948 |
|
|
2016
Q4 | – | Sell |
-307
| Closed | -$52.3K | – | 5827 |
|
|
2016
Q3 | $50K | Buy |
307
+250
| +439% | +$37.9K | ﹤0.01% | 2100 |
|
|
2016
Q2 | $8K | Sell |
57
-209
| -79% | -$29.8K | ﹤0.01% | 3780 |
|
|
2016
Q1 | $36K | Buy |
266
+146
| +122% | +$19.2K | ﹤0.01% | 2247 |
|
|
2015
Q4 | $16K | Sell |
120
-617
| -84% | -$85.5K | ﹤0.01% | 2873 |
|
|
2015
Q3 | $98K | Sell |
737
-198
| -21% | -$28.5K | 0.01% | 1429 |
|
|
2015
Q2 | $140K | Buy |
+935
| New | +$134K | 0.01% | 998 |
|
Other funds holding BIO
AI
Simplex Trading's BIO Position: Q2 2026 in Review
Simplex Trading increased its Bio-Rad Laboratories Class A (BIO) stake by 11% in Q2 2026, buying an estimated $3.69K and bringing the position to 136 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6511.
Simplex Trading first reported a position in BIO in Q2 2015 and has held it in 24 quarters since. The position peaked at $893K in Q3 2022. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Simplex Trading held 136 shares of Bio-Rad Laboratories Class A worth $39.9K as of Q2 2026.
- Simplex Trading bought 13 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $3.69K.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6511 holding.
- Simplex Trading first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and has held it in 24 quarters since.
- Simplex Trading's Bio-Rad Laboratories Class A position peaked at $893K in Q3 2022.
- 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.